|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/04 | |
| C07D 409/14 | |||
| A61K 31/5365 | |||
| A61P 31/14 | |||
| A61K 45/06 |
| (11) | Number of the document | 2945952 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13871363.1 |
| Date of filing the European patent application | 2013-12-31 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2013/001676 |
| Date | 2013-12-31 |
| (87) | Number | WO 2014/110705 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| PCT/CN2013/0000 | 2013-01-16 | WO |
| (72) |
YU, Wensheng, US
TONG, Ling, US
KOZLOWSKI, Joseph A., US
SELYUTIN, Oleg, US
CHEN, Lei, US
KIM, Jae-Hun, US
SHA, Deyou, US
RIZVI, Razia, US
SHANKAR, Bandarpalle, US
HU, Bin, CN
ZHONG, Bin, CN
WANG, Dahai, CN
HAO, Jinglai, CN
WEI, Wei, CN
JI, Tao, CN
ZAN, Shuai, CN
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES |
| HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES |